Century Therapeutics: Q4 Earnings Insights - Century Therapeutics (NASDAQ:IPSC)

Century Therapeutics IPSC reported its Q4 earnings results on Thursday, March 14, 2024 at 07:30 AM.

Here's what investors need to know about the announcement.

Century Therapeutics missed estimated earnings by -18.0%, reporting an EPS of $-0.65 versus an estimate of $-0.55.

Revenue was down $253 thousand from the same period last year.

Last quarter the company missed on EPS by $0.04 which was followed by a 7.000000000000001% drop in the share price the next day.

Here's a look at Century Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.51	-0.54	-0.52	-0.59
EPS Actual	-0.55	-0.56	-0.53	-0.55
Revenue Estimate	1.16M	1.14M	1.31M	1.97M
Revenue Actual	148K	99K	1.72M	521K

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Century Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.